0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Transforming Growth Factor Beta 1 Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
Published Date: July 2021
|
Report Code: QYRE-Auto-12A244
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Transforming Growth Factor Beta 1 Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Transforming Growth Factor Beta 1 Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-12A244
Report
July 2021
128 Pages
QYResearch
Region: Global, North America, Asia Pacific, Europe, Central & South America, Middle East, Africa,
Description
Table of Content
Tables & Figures
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
North America is the largest Transforming Growth Factor Beta 1 market with about 69% market share. Europe is follower, accounting for about 16% market share.The key manufacturers are Roche, Shionogi Ltd, Acceleron Pharma Inc, Genzyme Corp, Isarna Therapeutics GmbH, Scholar Rock, Sirnaomics Inc, Eli Lilly and Co, Formation Biologics Inc, Novartis AG etc.
Market Analysis and Insights: Global Transforming Growth Factor Beta 1 Market

In 2020, the global Transforming Growth Factor Beta 1 market size was US$ 1309.8 million and it is expected to reach US$ 2742.2 million by the end of 2027, with a CAGR of 11.1% during 2021-2027.

Global Transforming Growth Factor Beta 1 Scope and Market Size
Transforming Growth Factor Beta 1 market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Transforming Growth Factor Beta 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Transforming Growth Factor Beta 1 market is segmented into

Pirfenidone
Galunisertib
Others

Segment by Application, the Transforming Growth Factor Beta 1 market is segmented into

IPF
Cancer
Others
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape and Transforming Growth Factor Beta 1 Market Share Analysis
Transforming Growth Factor Beta 1 market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Transforming Growth Factor Beta 1 product introduction, recent developments, Transforming Growth Factor Beta 1 sales by region, type, application and by sales channel.
The major companies include:
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
1 Study Coverage
1.1 Transforming Growth Factor Beta 1 Product Introduction
1.2 Market by Type
1.2.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Market by Application
1.3.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts
2.1.1 Global Transforming Growth Factor Beta 1 Revenue 2016-2027
2.1.2 Global Transforming Growth Factor Beta 1 Sales 2016-2027
2.2 Transforming Growth Factor Beta 1 Market Size by Region: 2021 Versus 2027
2.3 Transforming Growth Factor Beta 1 Sales by Region (2016-2027)
2.3.1 Global Transforming Growth Factor Beta 1 Sales by Region: 2016-2021
2.3.2 Global Transforming Growth Factor Beta 1 Sales Forecast by Region (2022-2027)
2.3.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2016-2027)
2.4 Transforming Growth Factor Beta 1 Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Transforming Growth Factor Beta 1 Revenue by Region: 2016-2021
2.4.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2022-2027)
2.4.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2016-2027)
3 Global Transforming Growth Factor Beta 1 by Manufacturers
3.1 Global Top Transforming Growth Factor Beta 1 Manufacturers by Sales
3.1.1 Global Transforming Growth Factor Beta 1 Sales by Manufacturer (2016-2021)
3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Transforming Growth Factor Beta 1 Manufacturers by Revenue
3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Manufacturer (2016-2021)
3.2.2 Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturer (2016-2021)
3.3 Global Transforming Growth Factor Beta 1 Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Transforming Growth Factor Beta 1 Manufacturers Covered: Ranking by Revenue
3.4.2 Global Transforming Growth Factor Beta 1 Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Product Type
3.5.1 Transforming Growth Factor Beta 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Transforming Growth Factor Beta 1 Product Type
3.5.3 Date of International Manufacturers Enter into Transforming Growth Factor Beta 1 Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Roche
4.1.1 Roche Corporation Information
4.1.2 Roche Description, Business Overview
4.1.3 Roche Transforming Growth Factor Beta 1 Products Offered
4.1.4 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Roche Transforming Growth Factor Beta 1 Revenue by Product
4.1.6 Roche Transforming Growth Factor Beta 1 Revenue by Application
4.1.7 Roche Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.1.8 Roche Transforming Growth Factor Beta 1 Revenue by Sales Channel
4.1.9 Roche Recent Development
4.2 Shionogi Ltd
4.2.1 Shionogi Ltd Corporation Information
4.2.2 Shionogi Ltd Description, Business Overview
4.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Products Offered
4.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Shionogi Ltd Transforming Growth Factor Beta 1 Revenue by Product
4.2.6 Shionogi Ltd Transforming Growth Factor Beta 1 Revenue by Application
4.2.7 Shionogi Ltd Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.2.8 Shionogi Ltd Transforming Growth Factor Beta 1 Revenue by Sales Channel
4.2.9 Shionogi Ltd Recent Development
4.3 Acceleron Pharma Inc
4.3.1 Acceleron Pharma Inc Corporation Information
4.3.2 Acceleron Pharma Inc Description, Business Overview
4.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Products Offered
4.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue by Product
4.3.6 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue by Application
4.3.7 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.3.8 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue by Sales Channel
4.3.9 Acceleron Pharma Inc Recent Development
4.4 Genzyme Corp
4.4.1 Genzyme Corp Corporation Information
4.4.2 Genzyme Corp Description, Business Overview
4.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Products Offered
4.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Genzyme Corp Transforming Growth Factor Beta 1 Revenue by Product
4.4.6 Genzyme Corp Transforming Growth Factor Beta 1 Revenue by Application
4.4.7 Genzyme Corp Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.4.8 Genzyme Corp Transforming Growth Factor Beta 1 Revenue by Sales Channel
4.4.9 Genzyme Corp Recent Development
4.5 Isarna Therapeutics GmbH
4.5.1 Isarna Therapeutics GmbH Corporation Information
4.5.2 Isarna Therapeutics GmbH Description, Business Overview
4.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Products Offered
4.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue by Product
4.5.6 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue by Application
4.5.7 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.5.8 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue by Sales Channel
4.5.9 Isarna Therapeutics GmbH Recent Development
4.6 Scholar Rock
4.6.1 Scholar Rock Corporation Information
4.6.2 Scholar Rock Description, Business Overview
4.6.3 Scholar Rock Transforming Growth Factor Beta 1 Products Offered
4.6.4 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Scholar Rock Transforming Growth Factor Beta 1 Revenue by Product
4.6.6 Scholar Rock Transforming Growth Factor Beta 1 Revenue by Application
4.6.7 Scholar Rock Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.6.8 Scholar Rock Recent Development
4.7 Sirnaomics Inc
4.7.1 Sirnaomics Inc Corporation Information
4.7.2 Sirnaomics Inc Description, Business Overview
4.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Products Offered
4.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.7.5 Sirnaomics Inc Transforming Growth Factor Beta 1 Revenue by Product
4.7.6 Sirnaomics Inc Transforming Growth Factor Beta 1 Revenue by Application
4.7.7 Sirnaomics Inc Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.7.8 Sirnaomics Inc Recent Development
4.8 Eli Lilly and Co
4.8.1 Eli Lilly and Co Corporation Information
4.8.2 Eli Lilly and Co Description, Business Overview
4.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Products Offered
4.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Eli Lilly and Co Transforming Growth Factor Beta 1 Revenue by Product
4.8.6 Eli Lilly and Co Transforming Growth Factor Beta 1 Revenue by Application
4.8.7 Eli Lilly and Co Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.8.8 Eli Lilly and Co Recent Development
4.9 Formation Biologics Inc
4.9.1 Formation Biologics Inc Corporation Information
4.9.2 Formation Biologics Inc Description, Business Overview
4.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Products Offered
4.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Formation Biologics Inc Transforming Growth Factor Beta 1 Revenue by Product
4.9.6 Formation Biologics Inc Transforming Growth Factor Beta 1 Revenue by Application
4.9.7 Formation Biologics Inc Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.9.8 Formation Biologics Inc Recent Development
4.10 Novartis AG
4.10.1 Novartis AG Corporation Information
4.10.2 Novartis AG Description, Business Overview
4.10.3 Novartis AG Transforming Growth Factor Beta 1 Products Offered
4.10.4 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Novartis AG Transforming Growth Factor Beta 1 Revenue by Product
4.10.6 Novartis AG Transforming Growth Factor Beta 1 Revenue by Application
4.10.7 Novartis AG Transforming Growth Factor Beta 1 Revenue by Geographic Area
4.10.8 Novartis AG Recent Development
5 Breakdown Data by Type
5.1 Global Transforming Growth Factor Beta 1 Sales by Type (2016-2027)
5.1.1 Global Transforming Growth Factor Beta 1 Sales by Type (2016-2021)
5.1.2 Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2022-2027)
5.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2027)
5.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2016-2027)
5.2.1 Global Transforming Growth Factor Beta 1 Revenue by Type (2016-2021)
5.2.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2022-2027)
5.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2016-2027)
5.3 Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Transforming Growth Factor Beta 1 Sales by Application (2016-2027)
6.1.1 Global Transforming Growth Factor Beta 1 Sales by Application (2016-2021)
6.1.2 Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2022-2027)
6.1.3 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2027)
6.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2016-2027)
6.2.1 Global Transforming Growth Factor Beta 1 Revenue by Application (2016-2021)
6.2.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2022-2027)
6.2.3 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2016-2027)
6.3 Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Transforming Growth Factor Beta 1 Market Size YoY Growth 2016-2027
7.2 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
7.2.1 North America Transforming Growth Factor Beta 1 Sales by Country (2016-2027)
7.2.2 North America Transforming Growth Factor Beta 1 Revenue by Country (2016-2027)
7.3 North America Transforming Growth Factor Beta 1 Sales by Type
7.4 North America Transforming Growth Factor Beta 1 Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Transforming Growth Factor Beta 1 Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Region
8.2.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Region (2016-2027)
8.2.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue by Region (2016-2027)
8.3 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Type
8.4 Asia-Pacific Transforming Growth Factor Beta 1 Sales by Application
9 Europe
9.1 Europe Transforming Growth Factor Beta 1 Market Size YoY Growth 2016-2027
9.2 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Country
9.2.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2016-2027)
9.2.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2016-2027)
9.3 Europe Transforming Growth Factor Beta 1 Sales by Type
9.4 Europe Transforming Growth Factor Beta 1 Sales by Application
10 Latin America
10.1 Latin America Transforming Growth Factor Beta 1 Market Size YoY Growth 2016-2027
10.2 Latin America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
10.2.1 Latin America Transforming Growth Factor Beta 1 Sales by Country (2016-2027)
10.2.2 Latin America Transforming Growth Factor Beta 1 Revenue by Country (2016-2027)
10.3 Latin America Transforming Growth Factor Beta 1 Sales by Type
10.4 Latin America Transforming Growth Factor Beta 1 Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Transforming Growth Factor Beta 1 Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Country
11.2.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2016-2027)
11.2.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2016-2027)
11.3 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type
11.4 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Transforming Growth Factor Beta 1 Supply Chain Analysis
12.2 Transforming Growth Factor Beta 1 Key Raw Materials and Upstream Suppliers
12.3 Transforming Growth Factor Beta 1 Clients Analysis
12.4 Transforming Growth Factor Beta 1 Sales Channel and Sales Model Analysis
12.4.1 Transforming Growth Factor Beta 1 Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Transforming Growth Factor Beta 1 Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Transforming Growth Factor Beta 1 Distributors
13 Market Dynamics
13.1 Transforming Growth Factor Beta 1 Market Drivers
13.2 Transforming Growth Factor Beta 1 Market Opportunities
13.3 Transforming Growth Factor Beta 1 Market Challenges
13.4 Transforming Growth Factor Beta 1 Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
    Table 2. Major Manufacturers of Pirfenidone
    Table 3. Major Manufacturers of Galunisertib
    Table 4. Major Manufacturers of Others
    Table 5. Global Transforming Growth Factor Beta 1 Market Size Growth by Application (US$ Million): 2021 VS 2027
    Table 6. Global Transforming Growth Factor Beta 1 Market Size by Region (US$ Million): 2021 VS 2027
    Table 7. Global Transforming Growth Factor Beta 1 Sales by Region (2016-2021) & (K Units)
    Table 8. Global Transforming Growth Factor Beta 1 Sales Forecast by Region (2022-2027) & (K Units)
    Table 9. Global Transforming Growth Factor Beta 1 Revenue by Region (2016-2021) & (US$ Million)
    Table 10. Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 11. Global Transforming Growth Factor Beta 1 Sales by Manufacturer (2016-2021) & (K Units)
    Table 12. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturer (2016-2021)
    Table 13. Transforming Growth Factor Beta 1 Revenue by Manufacturer (2016-2021) & (US$ Million)
    Table 14. Transforming Growth Factor Beta 1 Revenue Share by Manufacturer (2016-2021)
    Table 15. Key Manufacturers Transforming Growth Factor Beta 1 Price (2016-2021) & (USD/Unit)
    Table 16. Ranking of Global Top Transforming Growth Factor Beta 1 Manufacturers by Revenue (US$ Million) in 2020
    Table 17. Global Transforming Growth Factor Beta 1 Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 18. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transforming Growth Factor Beta 1 as of 2020)
    Table 19. Transforming Growth Factor Beta 1 Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Transforming Growth Factor Beta 1 Product Type
    Table 21. Date of International Manufacturers Enter into Transforming Growth Factor Beta 1 Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. Roche Corporation Information
    Table 24. Roche Description and Business Overview
    Table 25. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 26. Roche Transforming Growth Factor Beta 1 Product
    Table 27. Roche Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 28. Roche Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 29. Roche Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 30. Roche Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Sales Channel
    Table 31. Roche Recent Development
    Table 32. Shionogi Ltd Corporation Information
    Table 33. Shionogi Ltd Description and Business Overview
    Table 34. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 35. Shionogi Ltd Transforming Growth Factor Beta 1 Product
    Table 36. Shionogi Ltd Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 37. Shionogi Ltd Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 38. Shionogi Ltd Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 39. Shionogi Ltd Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Sales Channel
    Table 40. Shionogi Ltd Recent Development
    Table 41. Acceleron Pharma Inc Corporation Information
    Table 42. Acceleron Pharma Inc Description and Business Overview
    Table 43. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 44. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product
    Table 45. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 46. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 47. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 48. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Sales Channel
    Table 49. Acceleron Pharma Inc Recent Development
    Table 50. Genzyme Corp Corporation Information
    Table 51. Genzyme Corp Description and Business Overview
    Table 52. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 53. Genzyme Corp Transforming Growth Factor Beta 1 Product
    Table 54. Genzyme Corp Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 55. Genzyme Corp Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 56. Genzyme Corp Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 57. Genzyme Corp Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Sales Channel
    Table 58. Genzyme Corp Recent Development
    Table 59. Isarna Therapeutics GmbH Corporation Information
    Table 60. Isarna Therapeutics GmbH Description and Business Overview
    Table 61. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 62. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product
    Table 63. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 64. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 65. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 66. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Sales Channel
    Table 67. Isarna Therapeutics GmbH Recent Development
    Table 68. Scholar Rock Corporation Information
    Table 69. Scholar Rock Description and Business Overview
    Table 70. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 71. Scholar Rock Transforming Growth Factor Beta 1 Product
    Table 72. Scholar Rock Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 73. Scholar Rock Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 74. Scholar Rock Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 75. Scholar Rock Recent Development
    Table 76. Sirnaomics Inc Corporation Information
    Table 77. Sirnaomics Inc Description and Business Overview
    Table 78. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 79. Sirnaomics Inc Transforming Growth Factor Beta 1 Product
    Table 80. Sirnaomics Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 81. Sirnaomics Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 82. Sirnaomics Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 83. Sirnaomics Inc Recent Development
    Table 84. Eli Lilly and Co Corporation Information
    Table 85. Eli Lilly and Co Description and Business Overview
    Table 86. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 87. Eli Lilly and Co Transforming Growth Factor Beta 1 Product
    Table 88. Eli Lilly and Co Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 89. Eli Lilly and Co Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 90. Eli Lilly and Co Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 91. Eli Lilly and Co Recent Development
    Table 92. Formation Biologics Inc Corporation Information
    Table 93. Formation Biologics Inc Description and Business Overview
    Table 94. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 95. Formation Biologics Inc Transforming Growth Factor Beta 1 Product
    Table 96. Formation Biologics Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 97. Formation Biologics Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 98. Formation Biologics Inc Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 99. Formation Biologics Inc Recent Development
    Table 100. Novartis AG Corporation Information
    Table 101. Novartis AG Description and Business Overview
    Table 102. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
    Table 103. Novartis AG Transforming Growth Factor Beta 1 Product
    Table 104. Novartis AG Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Product
    Table 105. Novartis AG Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Application
    Table 106. Novartis AG Transforming Growth Factor Beta 1 Revenue (US$ Million) and Market Share by Geographic Area
    Table 107. Novartis AG Recent Development
    Table 108. Global Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
    Table 109. Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2022-2027) & (K Units)
    Table 110. Global Transforming Growth Factor Beta 1 Revenue by Type (2016-2021) & (US$ Million)
    Table 111. Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 112. Global Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
    Table 113. Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2022-2027) & (K Units)
    Table 114. Global Transforming Growth Factor Beta 1 Revenue by Application (2016-2021) & (US$ Million)
    Table 115. Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 116. North America Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)
    Table 117. North America Transforming Growth Factor Beta 1 Sales by Country (2022-2027) & (K Units)
    Table 118. North America Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & (US$ Million)
    Table 119. North America Transforming Growth Factor Beta 1 Revenue by Country (2022-2027) & (US$ Million)
    Table 120. North America Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
    Table 121. North America Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
    Table 122. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Region (2016-2021) & (K Units)
    Table 123. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Region (2022-2027) & (K Units)
    Table 124. Asia-Pacific Transforming Growth Factor Beta 1 Revenue by Region (2016-2027) & (US$ Million)
    Table 125. Asia-Pacific Transforming Growth Factor Beta 1 Revenue by Region (2022-2027) & (US$ Million)
    Table 126. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
    Table 127. Asia-Pacific Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
    Table 128. Europe Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)
    Table 129. Europe Transforming Growth Factor Beta 1 Sales by Country (2022-2027) & (K Units)
    Table 130. Europe Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & (US$ Million)
    Table 131. Europe Transforming Growth Factor Beta 1 Revenue by Country (2022-2027) & (US$ Million)
    Table 132. Europe Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
    Table 133. Europe Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
    Table 134. Latin America Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)
    Table 135. Latin America Transforming Growth Factor Beta 1 Sales by Country (2022-2027) & (K Units)
    Table 136. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & (US$ Million)
    Table 137. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2022-2027) & (US$ Million)
    Table 138. Latin America Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
    Table 139. Latin America Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
    Table 140. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2016-2021) & (K Units)
    Table 141. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2022-2027) & (K Units)
    Table 142. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2016-2021) & (US$ Million)
    Table 143. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2022-2027) & (US$ Million)
    Table 144. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2016-2021) & (K Units)
    Table 145. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2016-2021) & (K Units)
    Table 146. Transforming Growth Factor Beta 1 Key Raw Materials, Industry Status and Trend
    Table 147. Transforming Growth Factor Beta 1 Key Raw Materials and Upstream Suppliers
    Table 148. Transforming Growth Factor Beta 1 Clients Status and Trend
    Table 149. Transforming Growth Factor Beta 1 Typical Clients
    Table 150. Transforming Growth Factor Beta 1 Distributors
    Table 151. Key Drivers: Impact Analysis (2022-2027)
    Table 152. Transforming Growth Factor Beta 1 Market Drivers
    Table 153. Transforming Growth Factor Beta 1 Market Opportunities
    Table 154. Transforming Growth Factor Beta 1 Market Challenges
    Table 155. Transforming Growth Factor Beta 1 Market Restraints
    Table 156. Transforming Growth Factor Beta 1 Porter’s Five Forces Analysis
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Transforming Growth Factor Beta 1 Product Picture
    Figure 2. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2021 & 2027
    Figure 3. Pirfenidone Product Picture
    Figure 4. Galunisertib Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Transforming Growth Factor Beta 1 Sales Market Share by Application in 2021 & 2027
    Figure 7. IPF Examples
    Figure 8. Cancer Examples
    Figure 9. Others Examples
    Figure 10. Transforming Growth Factor Beta 1 Report Years Considered
    Figure 11. Global Transforming Growth Factor Beta 1 Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Transforming Growth Factor Beta 1 Market Size 2016-2027 (US$ Million)
    Figure 13. Global Transforming Growth Factor Beta 1 Sales 2016-2027 (K Units)
    Figure 14. Global Transforming Growth Factor Beta 1 Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Region (2016-2027)
    Figure 16. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2016-2027)
    Figure 17. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturer in 2020
    Figure 18. Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 19. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2016-2027)
    Figure 20. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Type (2016-2027)
    Figure 21. Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
    Figure 22. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Application (2016-2027)
    Figure 23. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Application (2016-2027)
    Figure 24. Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
    Figure 25. North America Transforming Growth Factor Beta 1 Revenue 2016-2027 (US$ Million)
    Figure 26. North America Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
    Figure 27. North America Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
    Figure 28. Asia-Pacific Transforming Growth Factor Beta 1 Revenue 2016-2027 (US$ Million)
    Figure 29. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region (2016-2027)
    Figure 30. Asia-Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region (2016-2027)
    Figure 31. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
    Figure 32. Asia-Pacific Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
    Figure 33. Europe Transforming Growth Factor Beta 1 Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 34. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2027)
    Figure 35. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2027)
    Figure 36. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
    Figure 37. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
    Figure 38. Latin America Transforming Growth Factor Beta 1 Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 39. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2027)
    Figure 40. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2021)
    Figure 41. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
    Figure 42. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
    Figure 43. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 44. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2016-2027)
    Figure 45. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2016-2027)
    Figure 46. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2016-2021)
    Figure 47. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2016-2021)
    Figure 48. Transforming Growth Factor Beta 1 Supply Chain (Upstream and Downstream Market)
    Figure 49. Global Production Market Share of Transforming Growth Factor Beta 1 Raw Materials by Region in 2020
    Figure 50. Transforming Growth Factor Beta 1 Distribution Channels
    Figure 51. Global Transforming Growth Factor Beta 1 Percentage 2016-2027: Indirect Sales VS Direct Sales
    Figure 52. Global Transforming Growth Factor Beta 1 Percentage 2016-2027: Online Sales VS Offline Sales
    Figure 53. Porter's Five Forces Analysis
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Torasemide API Market Research Report 2022
Global Torasemide API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-37B11450
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Baloxavir Marboxil API Market Research Report 2022
Global Baloxavir Marboxil API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-39E11527
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29D11405
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Chemiluminescence Immunodiagnostic Market Research Report 2022
Global Chemiluminescence Immunodiagnostic Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-18X11631
Fri Aug 12 00:00:00 UTC 2022

Add to Cart